DMT-210

N/A

Report date: 2022/11/25 18:11:02
NME

Base Information

Drug NameDMT-210
Drug Alias NameDMT-200DMT-210DMT-220SIG-990
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-6 inhibitorsG-protein coupled receptor modulatorsToll like receptor 4 modulators +[7] 
TargetsGTP-binding proteinsG-protein coupled receptorToll like receptor 4 +[7] 
Therapy Area/IndicationsRosaceaDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSignum Dermalogix
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDermata Therapeutics Llc
Active IndicationsN/A
Inactive IndicationsRosaceaDermatitis, Atopic

Other Information

ATC CodeN/A
Related LinksN/A